Permanently Discontinued

CLINOLEIC 20%

BAXTER CORPORATION

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is CLINOLEIC 20% discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that CLINOLEIC 20% 4% 16% has been permanently discontinued (last updated January 1, 2018). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is CLINOLEIC 20% not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Check with your pharmacist

StatusPermanently Discontinued

Same-ingredient products on fileNone found

Affected strength4% 16%

Last updated2018-01-01

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02344327

Strength

4% 16%

Dosage Form

EMULSION

Route

INTRAVENOUS

Active Ingredient

SOYBEAN OIL OLIVE OIL

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

2018-01-01

Permanently Discontinued

Business reasons

Other Products from BAXTER CORPORATION

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

(20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP

DIN 00438014

(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP

DIN 00786292

(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP

DIN 00438049

(20MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP

DIN 00786209

(20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP

DIN 00437999

(40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP

DIN 00786217